- Home
- SHG vs ITCI Comparison
SHG vs ITCI Comparison
Compare SHG & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHG
- ITCI
- Stock Information
- Founded
- SHG 1982
- ITCI 2002
- Country
- SHG South Korea
- ITCI United States
- Employees
- SHG N/A
- ITCI N/A
- Industry
- SHG Major Banks
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- SHG Finance
- ITCI Health Care
- Exchange
- SHG Nasdaq
- ITCI Nasdaq
- Market Cap
- SHG N/A
- ITCI 13.5B
- IPO Year
- SHG N/A
- ITCI N/A
- Fundamental
- Price
- SHG $31.76
- ITCI $131.81
- Analyst Decision
- SHG
- ITCI Buy
- Analyst Count
- SHG 0
- ITCI 13
- Target Price
- SHG N/A
- ITCI $106.58
- AVG Volume (30 Days)
- SHG 273.4K
- ITCI 2.0M
- Earning Date
- SHG 04-25-2025
- ITCI 05-06-2025
- Dividend Yield
- SHG 1.83%
- ITCI N/A
- EPS Growth
- SHG 4.89
- ITCI N/A
- EPS
- SHG 5.71
- ITCI N/A
- Revenue
- SHG $9,891,717,986.00
- ITCI $680,852,000.00
- Revenue This Year
- SHG $3.49
- ITCI $40.64
- Revenue Next Year
- SHG $2.89
- ITCI $58.53
- P/E Ratio
- SHG $5.60
- ITCI N/A
- Revenue Growth
- SHG 2.76
- ITCI 46.62
- 52 Week Low
- SHG $29.25
- ITCI $64.09
- 52 Week High
- SHG $46.05
- ITCI $131.87
- Technical
- Relative Strength Index (RSI)
- SHG 46.12
- ITCI 85.59
- Support Level
- SHG $32.32
- ITCI $131.19
- Resistance Level
- SHG $33.57
- ITCI $131.79
- Average True Range (ATR)
- SHG 0.39
- ITCI 0.13
- MACD
- SHG 0.16
- ITCI -0.41
- Stochastic Oscillator
- SHG 57.94
- ITCI 91.18
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.